SC 13G/A

AMENDMENT NO. 4 TO SCHEDULE 13G

Company: Protalix BioTherapeutics, Inc.
Filed: February 13, 2020
Accession Number: 0001213900-20-003571

View Document ↗ View on SEC.gov ↗